A Lawrence Gould

发表

BMA‐Mod: A Bayesian model averaging strategy for determining dose‐response relationships in the presence of model uncertainty

A Lawrence Gould, A. Gould, 2018, Biometrical journal. Biometrische Zeitschrift.

Detecting potential safety issues in clinical trials by Bayesian screening.

A Lawrence Gould, 2008, Biometrical journal. Biometrische Zeitschrift.

Principled Structured Incorporation of Clinical Knowledge Into Strategic Development Decisions

A Lawrence Gould, Rajesh Krishna, Jeffrey Saltzman, 2015, Therapeutic innovation & regulatory science.

Accounting for Multiplicity in the Evaluation of “Signals” Obtained by Data Mining from Spontaneous Report Adverse Event Databases

A Lawrence Gould, A. Gould, 2007, Biometrical journal. Biometrische Zeitschrift.

Methods and Issues to Consider for Detection of Safety Signals From Spontaneous Reporting Databases: A Report of the DIA Bayesian Safety Signal Detection Working Group

Haoda Fu, A Lawrence Gould, Theodore C Lystig, 2015, Therapeutic innovation & regulatory science.

Practical pharmacovigilance analysis strategies.

A Lawrence Gould, A. Gould, 2003, Pharmacoepidemiology and drug safety.

On the inappropriateness of an EM algorithm based procedure for blinded sample size re‐estimation by T. Friede and M. Kieser, Statistics in Medicine 2002; 21:165‐‐176

A Lawrence Gould, W. Shih, Weichung J Shih, 2005, Statistics in medicine.

COMPARISON OF ALTERNATIVE STRATEGIES FOR ANALYSIS OF LONGITUDINAL TRIALS WITH DROPOUTS

A Lawrence Gould, Guanghan Liu, A. Gould, 2002, Journal of biopharmaceutical statistics.

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib.

A Lawrence Gould, Christopher P Cannon, Bruce Binkowitz, 2009, American heart journal.

Bayesian analysis of multicentre trial outcomes

A Lawrence Gould, A. Gould, 2005, Statistical methods in medical research.